Ibithral 250 Tablet contains Azithromycin 250 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. Azithromycin works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication. Ibithral 250 is commonly prescribed for the treatment of respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as skin and soft tissue infections, otitis media, and certain sexually transmitted infections including chlamydia. It is also utilized in the management of pharyngitis and tonsillitis caused by susceptible strains of bacteria. The drug is well-absorbed orally, with a prolonged half-life allowing for once-daily dosing and shorter treatment courses compared to other antibiotics. Ibithral 250 should be taken as directed by a healthcare professional, typically on an empty stomach to enhance absorption. Caution is advised in patients with known hypersensitivity to macrolides or with a history of liver disease. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. It is important to complete the full prescribed course to prevent the development of antibiotic resistance. Ibithral 250 is contraindicated in patients with known QT prolongation or those taking medications that may interact adversely with azithromycin.